• Focus Areas
    • Cause Selection
    • Global Health & Wellbeing
      • EA Community Growth (Global Health and Wellbeing)
      • Farm Animal Welfare
      • Global Aid Policy
      • Global Health & Development
      • Scientific Research
      • South Asian Air Quality
    • Longtermism
      • Biosecurity & Pandemic Preparedness
      • Effective Altruism Community Growth
      • Potential Risks from Advanced AI
    • Other Areas
      • Criminal Justice Reform
      • History of Philanthropy
      • Immigration Policy
      • Land Use Reform
      • Macroeconomic Stabilization Policy
  • Grants
  • Research & Updates
    • Research Reports
    • Blog Posts
    • Notable Lessons
    • In the News
  • About Us
    • Grantmaking Process
    • How to Apply for Funding
    • Team
    • Stay Updated
  • We’re hiring!
  • Focus Areas
    • Cause Selection
    • Global Health & Wellbeing
      • EA Community Growth (Global Health and Wellbeing)
      • Farm Animal Welfare
      • Global Aid Policy
      • Global Health & Development
      • Scientific Research
      • South Asian Air Quality
    • Longtermism
      • Biosecurity & Pandemic Preparedness
      • Effective Altruism Community Growth
      • Potential Risks from Advanced AI
    • Other Areas
      • Criminal Justice Reform
      • History of Philanthropy
      • Immigration Policy
      • Land Use Reform
      • Macroeconomic Stabilization Policy
  • Grants
  • Research & Updates
    • Research Reports
    • Blog Posts
    • Notable Lessons
    • In the News
  • About Us
    • Grantmaking Process
    • How to Apply for Funding
    • Team
    • Stay Updated
  • We’re hiring!

Schepens Eye Research Institute at Mass Eye and Ear — Pulmonary Fibrosis Drug (Leo Kim)

Visit Grantee Site
  • Focus Area: Scientific Research
  • Organization Name: Mass Eye and Ear
  • Amount: $920,000

  • Award Date: July 2021

Table of Contents

    Open Philanthropy recommended a grant of $920,000 to Mass Eye and Ear to support research led by Leo Kim, of Mass Eye and Ear and Harvard Medical School, on a drug to treat pulmonary fibrosis in patients with COVID-19 and other causes. Pulmonary fibrosis is a chronic and often fatal lung disease that affects approximately 3.5 million people worldwide, in addition to a significant number of patients hospitalized with COVID-19.

    This falls within our work on scientific research, specifically within our interest in human health and wellbeing.

    Related Items

    • Scientific Research

      Stanford University — Research on Science and Innovation (Heidi Williams)

      Open Philanthropy recommended a grant of $600,823 to Stanford University to support a one-year period of research leave for Professor Heidi Williams. During this time, Professor Williams will pursue research...

      Read more
    • Scientific Research

      University of California, San Francisco Foundation — Reproductive Medicine Research

      Open Philanthropy recommended a grant of $550,000 over 18 months to the University of California, San Francisco (UCSF) Foundation to support research led by Professor Paolo Rinaudo on...

      Read more
    • Scientific Research

      University of Connecticut Health Center — Syphilis Vaccine Development

      Open Philanthropy recommended a grant of $4,563,250 to the University of Connecticut Health Center to support work by Kelly Hawley and Melissa Caimano on the development of a...

      Read more
    Back to Grants Database
    Open Philanthropy
    Open Philanthropy
    • Careers
    • Press Kit
    • Governance
    • Privacy Policy
    Mailing Address
    182 Howard Street #225
    San Francisco, CA 94105
    Email
    [email protected]
    Media Inquiries
    [email protected]
    Anonymous Feedback
    Feedback Form

    Sign Up to Follow Our Work

    Join Our Mailing List

    © Open Philanthropy 2022